ESSLINGER; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for ESSLINGER; Christoph.The latest application filed is for "method for recovering two or more genes, or gene products, encoding an immunoreceptor".

Company Profile

5.9.24

ESSLINGER; Christoph - Zurich CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Recovering Two Or More Genes, Or Gene Products, Encoding An Immunoreceptor App 20220127599 - HELD; Martin ; et al.	2022-04-28
Method for recovering two or more genes, or gene products, encoding an immunoreceptor Grant 11,312,952 - Held , et al. April 26, 2	2022-04-26
Method Of Providing Disease-specific Binding Molecules And Targets App 20190263896 - Nitsch; Roger ; et al.	2019-08-29
Method Of Providing Disease-specific Binding Molecules And Targets App 20190153082 - Nitsch; Roger ; et al.	2019-05-23
Method of providing disease-specific binding molecules and targets Grant 10,202,445 - Nitsch , et al. Feb	2019-02-12
Combination therapy including tumor associated antigen binding antibodies App 20180353603 - Esslinger; Christoph ; et al.	2018-12-13
Methods of treating Alzheimer's disease Grant 10,131,708 - Nitsch , et al. November 20, 2	2018-11-20
Method of Providing Disease-Specific Binding Molecules and Targets App 20180134773 - Nitsch; Roger ; et al.	2018-05-17
Method of providing disease-specific binding molecules and targets Grant 9,828,420 - Nitsch , et al. November 28, 2	2017-11-28
Method Of Providing Disease-specific Binding Molecules And Targets App 20170283491 - Nitsch; Roger ; et al.	2017-10-05
Method of providing disease-specific binding molecules and targets Grant 9,670,272 - Nitsch , et al. June 6, 2	2017-06-06
Method For Recovering Two Or More Genes, Or Gene Products, Encoding An Immunoreceptor App 20170044523 - HELD; Martin ; et al.	2017-02-16
Method of Providing Disease-Specific Binding Molecules and Targets App 20160289310 - Nitsch; Roger ; et al.	2016-10-06
Method Of Providing Disease-specific Binding Molecules And Targets App 20150147343 - NITSCH; Roger ; et al.	2015-05-28
Method of providing disease-specific binding molecules and targets Grant 8,906,367 - Nitsch , et al. December 9, 2	2014-12-09
Magea3 Binding Antibodies App 20140186363 - Esslinger; Christoph ; et al.	2014-07-03
Magea3 Binding Antibodies App 20140093514 - Esslinger; Christoph ; et al.	2014-04-03
Combination Therapy Including Tumor Associated Antigen Binding Antibodies App 20130295091 - Esslinger; Christoph ; et al.	2013-11-07
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266586 - NITSCH; Roger ; et al.	2013-10-10
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266585 - NITSCH; Roger ; et al.	2013-10-10
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266514 - NITSCH; Roger ; et al.	2013-10-10
Monoclonal human tumor-specific antibody Grant 8,519,106 - Esslinger , et al. August 27, 2	2013-08-27
Method Of Providing Disease-specific Binding Molecules And Targets App 20130216555 - NITSCH; Roger ; et al.	2013-08-22
Method Of Providing Immunoglobulin Secreting B Lymphocytes And Human Antibodies App 20110171688 - Esslinger; Christoph	2011-07-14
Method Of Providing Human Tumor-specific Antibodies App 20110123447 - Esslinger; Christoph ; et al.	2011-05-26
Monoclonal Human Tumor-specific Antibody App 20100330075 - Esslinger; Christoph ; et al.	2010-12-30
Method of Providing Disease-Specific Binding Molecules and Targets App 20100202968 - Nitsch; Roger ; et al.	2010-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.